期刊
CANCER LETTERS
卷 313, 期 2, 页码 137-144出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2011.05.030
关键词
Pancreatic cancer; Gemcitabine; Salinomycin; Combination treatment
类别
资金
- National Laboratory of Molecular Biology Special Foundation [2060204]
Previous research has documented that a subpopulation of pancreatic cancer cells, named cancer stem cells (CSCs), harbor stem cell-like properties. Here, we examined the efficacy of combined treatments of salinomycin and gemcitabine in human pancreatic cancer cells. Salinomycin inhibited the growth of CSCs, while gemcitabine suppressed the viability of non-CSCs. Consistently, in vivo studies showed that salinomycin combined with gemcitabine could eliminate the engraftment of human pancreatic cancer more effectively than the individual agents. These data indicated that administration of salinomycin, which targets CSCs, may constitute a potential therapeutic strategy for improving the efficacy of gemcitabine to eradicate pancreatic cancer. (C) 2011 Published by Elsevier Ireland Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据